Molecular Properties
| Parameter | Value |
|---|---|
| Chemical Name | Gonadotropin-Releasing Hormone / Luteinizing Hormone-Releasing Hormone (LHRH) |
| Amino Acid Sequence | pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂ |
| Molecular Formula | C₅₅H₇₅N₁₇O₁₃ |
| Molecular Weight | 1182.31 g/mol |
| CAS Number | 33515-09-2 |
| Sequence Length | 10 amino acids (decapeptide) |
| Receptor Target | GnRH receptor (GnRHR) on pituitary gonadotrophs |
Physical Properties
| Property | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder |
| Solubility | Soluble in water, PBS (pH 7.0-7.4), or 0.9% saline at ≥1 mg/mL |
| pH (1% solution) | 5.0 - 7.0 |
| Hygroscopicity | Low; standard desiccated storage acceptable |
| Solution Stability | Stable at 4°C for 7-10 days; degradation at room temperature within 24-48h |
Analytical Specifications
| Test | Specification |
|---|---|
| HPLC Purity | ≥98.0% |
| Mass Spectrometry | Confirmed [M+H]⁺ = 1182.31 ± 0.5 Da |
| Peptide Content | ≥95% (by amino acid analysis) |
| Endotoxin Level | <1.0 EU/mg |
| Acetate Content | ≤5% |
| TFA Content | ≤0.1% |
| Water Content | ≤6% (Karl Fischer) |
Storage Parameters
| Condition | Specification |
|---|---|
| Lyophilized Storage | -20°C, desiccated |
| Lyophilized Shelf Life | 24-36 months when stored properly |
| Reconstituted Storage | 2-8°C for up to 10 days; -20°C for up to 3 months |
| Analytical Stock Preparation | Dissolve in sterile water or PBS (pH 7.0-7.4) with gentle vortexing for 30 seconds |
| Freeze-Thaw Cycles | Maximum 3 cycles; single-use aliquoting recommended |
| Light Sensitivity | Minimal; standard laboratory storage acceptable |
In Vitro & Preclinical Model Concentrations
| Experimental Model | Published Concentration / Regimen | Exposure Schedule | Administration Context |
|---|---|---|---|
| In Vitro Pituitary Cell Assays | 1-100 nM | Acute stimulation (minutes to hours) | Culture media |
| Small Animal Models (Rodent) | 10-100 μg/kg (10-100 nmol/kg) | Single bolus or pulsatile (every 60-90 min) | IV, SC, IP in rodent models |
| LH/FSH Stimulation Assay (Animal) | 25-100 μg/kg | Single bolus | IV or SC in animal models |
| Reproductive Axis Studies (Animal) | 0.1-10 μg/animal | Pulsatile every 1-2 hours | IV infusion pump or bolus in animal models |
Note: Concentrations and animal regimens summarized above are for research reference only. Pulsatile delivery mimics physiological hypothalamic secretion patterns in experimental systems.
Key Research Studies
| Year | Study Focus | Key Findings |
|---|---|---|
| 1971 | Discovery and characterization | First isolation and sequencing of GnRH from porcine and ovine hypothalami; demonstrated decapeptide structure with pGlu N-terminus and Gly-NH₂ C-terminus critical for activity |
| 1982 | Pulsatile secretion pattern and receptor dynamics | Established that pulsatile GnRH delivery (60-90 min intervals) maintains gonadotropin secretion while continuous administration causes receptor desensitization and downregulation within 7-14 days |
| 1997 | Structure-activity relationship | Systematic amino acid substitutions revealed positions 1, 2, 3, 6, and 10 essential for receptor binding; modifications at positions 6 and 10 generated superagonists with 50-200x potency |
| 2008 | GnRH receptor signaling cascades | Detailed GnRHR signaling via Gq/11 → PKC activation → Ca²⁺ mobilization → ERK1/2 phosphorylation pathway; demonstrated EC₅₀ of 0.5-2 nM for LH secretion from primary pituitary cells |
Mechanism of Action
| Biological Pathway | Description |
|---|---|
| Receptor Binding | Binds GnRH receptor (GnRHR), a Gq-coupled GPCR on anterior pituitary gonadotrophs; high affinity with Kd ~1-5 nM |
| Signal Transduction | Activates phospholipase C → IP₃/DAG production → intracellular Ca²⁺ release → protein kinase C activation |
| Gonadotropin Secretion | Stimulates rapid release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from gonadotrophs within 5-15 minutes |
| Pulsatile Requirement | Physiological pulses every 60-120 minutes maintain LH/FSH; continuous exposure desensitizes receptors and suppresses gonadotropin output |
| Half-Life | 2-4 minutes (IV); rapid degradation by hypothalamic and pituitary peptidases |
Clinical Variants and Analogs
| Type | Examples | Key Modification |
|---|---|---|
| Native GnRH | Gonadorelin acetate | Natural sequence; short half-life |
| Superagonists | Triptorelin, Leuprolide, Goserelin | Position 6 and 10 substitutions; extended half-life and potency |
| Antagonists | Cetrorelix, Ganirelix, Degarelix | Multiple D-amino acid substitutions; competitive receptor blockade |
| Diagnostic Forms | Gonadorelin hydrochloride | Alternative salt form for diagnostic testing; equivalent activity |
Quality Control Parameters
| Test Method | Acceptance Criteria |
|---|---|
| Appearance (visual) | White to off-white powder; no aggregation or discoloration |
| Reconstitution Test | Complete dissolution within 1 minute; clear colorless solution |
| RP-HPLC (purity) | Main peak ≥98.0%; no single impurity >0.5% |
| ESI-MS (identity) | Observed [M+H]⁺ within ±0.05% of theoretical 1182.31 Da |
| Peptide Sequence Confirmation | N-terminal pGlu and C-terminal Gly-NH₂ verified by MS/MS |
Regulatory & Pharmaceutical History
Gonadorelin (as gonadorelin hydrochloride and gonadorelin acetate, under historical trade names including Factrel and Lutrepulse) has received FDA approval for diagnostic evaluation of hypothalamic-pituitary gonadotropic function and pulsatile induction of ovulation in primary hypothalamic amenorrhea. Research-grade gonadorelin documented in this monograph is intended strictly for in vitro and laboratory investigation.
External References
- Schally AV, et al. Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun. 1971;43(2):393-9. https://pubmed.ncbi.nlm.nih.gov/4930860/
- Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annu Rev Med. 1994;45:391-405. https://www.annualreviews.org/doi/10.1146/annurev.med.45.1.391
- National Center for Biotechnology Information. PubChem Compound Summary for Gonadorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Gonadorelin
